05.03.2014 Views

Understanding Facility Validation for GMP compliance - Indian ...

Understanding Facility Validation for GMP compliance - Indian ...

Understanding Facility Validation for GMP compliance - Indian ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Article<br />

<strong>Understanding</strong> <strong>Facility</strong> <strong>Validation</strong> <strong>for</strong><br />

<strong>GMP</strong> <strong>compliance</strong><br />

*J.Ramniwas, CEO<br />

Sai Pharma Solutions Inc., Vadodara.<br />

Introduction<br />

In the past decade, many farreaching<br />

changes have taken place in<br />

the application of c<strong>GMP</strong> regulations<br />

relating to the pharmaceutical industry.<br />

Continuous quality improvement thus<br />

is ingrained in the c<strong>GMP</strong> concept. The<br />

design, construction, commissioning, and<br />

validation of pharmaceutical facilities play<br />

a very important role in the risk mitigation<br />

of product quality and safety.<br />

<strong>Facility</strong> qualification (a part of validation<br />

that proves and documents that equipments<br />

or ancillary systems are properly installed,<br />

work correctly, and actually lead to the<br />

expected results) and validation (establishing<br />

documented evidence that provides a high<br />

degree of assurance that the manufacturing<br />

processes, including buildings, systems,<br />

and equipment consistently produce the<br />

desired results according to predetermined<br />

specifications and quality attributes)<br />

activities establish and provide documentary<br />

evidence that the facility is suitable <strong>for</strong> the<br />

intended use of manufacturing, testing and<br />

storage, meeting <strong>GMP</strong> requirements.<br />

The journey of facility validation starts<br />

from the conceptual design in mind, then<br />

on the piece of paper, be<strong>for</strong>e it takes the<br />

concrete shape. The facility validation<br />

protocol should cover the following<br />

in<strong>for</strong>mation but not limited to:<br />

1. Purpose<br />

2. Reason <strong>for</strong> establishing the protocol <strong>for</strong><br />

facility qualification<br />

3. Protocol Approval Signatures<br />

4. Scope<br />

5. <strong>Validation</strong> Team and Responsibilities<br />

Design Qualification<br />

The premises, supporting utilities,<br />

equipment, and processes have to<br />

be designed in accordance with the<br />

requirements of <strong>GMP</strong>. Design Qualification<br />

(DQ) consists of:<br />

1. <strong>Facility</strong> design in brief<br />

2. Critical attributes to be met while<br />

designing the facility<br />

3. Location and surroundings<br />

4. Premises<br />

4.1 Room number<br />

4.2 Activity to be per<strong>for</strong>med<br />

4.3 Room classification (e.g., class<br />

100, 10,000, etc.)<br />

4.4 Utilities required and their quality<br />

(e.g., WFI, distilled water,<br />

compressed air, etc.)<br />

4.5 Room finishes (floor, walls,<br />

ceilings, partitions)<br />

4.6 Illumination level requirement<br />

4.7 Safety features<br />

4.8 Pass-through<br />

4.9 Communicators<br />

4.10 Prefabricated partitions<br />

5. Paints<br />

6. Doors and view panels<br />

7. Electrical requirements<br />

8. Equipments<br />

Installation Qualification<br />

The premises, supporting utilities, and<br />

equipment have to be built and installed in<br />

<strong>compliance</strong> with their design specifications.<br />

This constitutes Installation Qualification<br />

(IQ). Purpose of installation qualification is<br />

to establish documented evidence that the<br />

facility has been designed and constructed<br />

as intended and deviations, if any, are<br />

justified & recorded. The facility Installation<br />

Qualification Protocol should cover the<br />

following details but not limited to:<br />

1. Purpose<br />

2. <strong>Facility</strong> layout<br />

3. Major facility verification<br />

3.1 <strong>Facility</strong> <strong>compliance</strong> assessment <strong>for</strong><br />

location, surrounding and premises<br />

3.2 Room datasheets<br />

3.3 Verification and confirmation of<br />

termite treatment/ pest control<br />

certificate<br />

4. Materials of Construction (MOC)<br />

5. Verification of utility supply<br />

6. Identification of facility and their status<br />

review<br />

7. Verification <strong>for</strong> facility installation<br />

8. Drawings<br />

9. Standard Operating System (SOPs)<br />

Identification<br />

10. Deficiency (if any) and corrective action<br />

report<br />

11. Justification <strong>for</strong> the changes in facility<br />

layout<br />

12. Deviations (if any)<br />

13. Acceptance criteria<br />

Operational Qualification<br />

The facilities, supporting utilities, and<br />

equipments operate in accordance with<br />

their design specifications. This constitutes<br />

Operational Qualification (OQ). Every<br />

room/ section on each floor shall be<br />

checked <strong>for</strong> flawless and smooth functioning<br />

of the following as applicable. Any<br />

discrepancy shall be identified, corrected<br />

and documented. The facility Operational<br />

Qualification Protocol should cover the<br />

following details but not limited to:<br />

1. Opening of doors<br />

2. Closing of doors<br />

3. Door Locks<br />

4. Door handles and hinges<br />

5. Door closure<br />

6. Light sources and their fixtures<br />

7. Illumination<br />

8. Electrical points and their earthing<br />

9. Water points<br />

10. Compressed air use points<br />

11. Air handling units/ HVAC systems<br />

12. Temperature<br />

13. Differential Pressure<br />

14. Drain Points<br />

15. Verification of Standard Operating<br />

Procedures<br />

16. Training Documentation<br />

17. Acceptance Criteria<br />

*Email id: jramniwas@saipharmasolutions.com<br />

Pharma Times - Vol. 44 - No. 02 - February 2012 13


Per<strong>for</strong>mance Qualification<br />

Per<strong>for</strong>mance Qualification of various<br />

support services provided in each<br />

room is detailed in the respective utility<br />

protocols. The preventive maintenance<br />

and routine cleaning and sanitization of<br />

facility is also the part of the per<strong>for</strong>mance<br />

qualification.<br />

Requalification Criteria<br />

1. Any change/ modification that is made<br />

in the facility design or layout must<br />

be requalified. The affected area<br />

shall be requalified and the room<br />

data sheet of the affected area shall<br />

be updated to incorporate the change(s)<br />

made.<br />

2. Any change made in the existing area<br />

support services or new or additional<br />

features are added to the room.<br />

Discussions and Summary<br />

From the data compiled, a summary<br />

report shall be prepared. Corporate technical<br />

team shall review and approve the final<br />

summary report prior to handling of the<br />

building <strong>for</strong> regular use.<br />

Attachments<br />

The following documents should be kept<br />

as an attachment with the facility validation<br />

protocol and report and should be updated<br />

with the justification of modification and<br />

changes:<br />

1. Approved Drawings<br />

2. Door Specifications<br />

3. Certificates<br />

A specific process will consistently<br />

produce a product meeting predetermined<br />

specifications and quality attributes. This<br />

constitutes Process <strong>Validation</strong> (PV) or<br />

Process Per<strong>for</strong>mance Qualification (PPQ).<br />

<strong>Facility</strong> validation covers all aspects<br />

of product and process risk management<br />

but after complying the facility qualification<br />

requirements, it is mandatory to the<br />

manufacturer to review periodically the<br />

facility qualification status. Generally, it<br />

has been observed that it is assumed by<br />

pharmaceutical manufacturers that once<br />

the facility is qualified, it will remain qualified<br />

throughout the life cycle of his business.<br />

But, at a particular juncture they realize<br />

that their world class manufacturing facility<br />

has become outdated and cannot be used<br />

anymore <strong>for</strong> the manufacturing purpose of<br />

medicinal products. The manufacturers of<br />

pharmaceuticals will have to bear in mind<br />

that what is prevalent today can become<br />

obsolete tomorrow and we have to keep<br />

pace with the changes taking place globally<br />

to remain in business <strong>for</strong>ever.<br />

Positions<br />

Advertisement Tariff <strong>for</strong><br />

Pharma Times<br />

New rates effective from 1/4/10<br />

For Color<br />

page<br />

(Rs.) Per<br />

insertion<br />

For B/W page<br />

(Rs.) Per<br />

Insertion<br />

Front Cover Gate Fold 50,000.00 –<br />

Back Cover 44,000.00 –<br />

Inside Front 30,000.00 –<br />

Inside Back 28,000.00 –<br />

First Page (Page 3) 30,000.00 –<br />

Last Page (Opp. Inside Back) 20,000.00 –<br />

Page Facing Content & Editorial Note 20,000.00 –<br />

Double Spread (Or Centre Spread) 35,000.00 –<br />

Full Page 16,000.00 10,000.00<br />

Half Page 9,000.00 6,000.00<br />

Quarter Page 5,000.00 3,500.00<br />

Discount <strong>for</strong> 1 to 3 insertion - 15%<br />

Discount <strong>for</strong> 4 to 6 insertions - 20%<br />

Discount <strong>for</strong> 7 to 12 insertions - 25%<br />

For Advertisements<br />

Mr. Ramesh Shah<br />

M/s. Kantilal N. Shah<br />

702, Corporate House, Opp. Dinesh Hall, Income Tax,<br />

Ashram Road, Ahmedabad - 380009, Gujarat.<br />

Ph.: 079-27540493, Fax: 079-30023754, Mobile: +91 93777 46368<br />

E-mail: kns_98@yahoo.com, kantilalnshah@gmail.com,<br />

Website: www.knsmedia.com<br />

Payment advance <strong>for</strong> every issue in the name of “M/s. Kantilal N. Shah”.<br />

Announcement<br />

National seminar<br />

On “Recent Advances in Drug Development & Research”<br />

On 03 rd March 2012 (Saturday)<br />

At P.D.M. College of Pharmacy,<br />

Sector- 3A, BahadurGarh<br />

Contact:<br />

Prof. (Dr.) Arun Garg - 09416056213<br />

Mr. Permender Rathee 09466593965<br />

Email id: pdmcop@rediffmail.com<br />

Advertisers’ Index<br />

Sr. No. Company Name Page No.<br />

1. Accin Packaging Pvt. Ltd................................................46<br />

2. Accupack Engineering Pvt. Ltd.......................................47<br />

3. Adam Fabriwerk Pvt. Ltd.................................................42<br />

4. Ambica Pharma Machines Pvt. Ltd.................................49<br />

5. Ami Polymer Pvt. Ltd.......................................................43<br />

6. Bectochem Consultants & Engineers Pvt. Ltd................44<br />

7. Bector Hecht Containment Technology Pvt. Ltd.............45<br />

8. Brothers Pharmamach (India) Pvt. Ltd............................10<br />

9. Cadmach Machinery Co. Pvt. Ltd...................................41<br />

10. Centre <strong>for</strong> Clinical Research & Training..........................40<br />

11. Dipesh Engineering Works................................................5<br />

12. Elmach Packages (India) Pvt. Ltd........................26,27, 50<br />

13. Fabtech Technologies International Ltd...................2,3,6,8<br />

14. Gitam University..............................................................40<br />

15. IMA-PG India Pvt Ltd........................................................4<br />

16. N. K. P. Pharma Pvt. Ltd.................................................25<br />

17. Precitech industries.........................................................28<br />

18. Promas Engineers Pvt. Ltd.............................................48<br />

19. Sanira Associates...........................................................28<br />

20. Target Innovations..........................................................43<br />

Pharma Times - Vol. 44 - No. 02 - February 2012 14

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!